Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2M Sell
48,000
-17,000
-26% -$4.64M 4.93% 8
2026
Q1
$10.5M Sell
65,000
-25,000
-28% -$4.13M 2.99% 14
2025
Q4
$9.86M Hold
90,000
3.06% 15
2025
Q3
$4.47M Hold
90,000
1.39% 20
2025
Q2
$4.08M Buy
90,000
+20,000
+29% +$894K 1.32% 21
2025
Q1
$3.27M Hold
70,000
1.05% 22
2024
Q4
$3.38M Hold
70,000
1.09% 21
2024
Q3
$2.95M Hold
70,000
0.86% 23
2024
Q2
$2.32M Buy
70,000
+25,000
+56% +$863K 0.76% 24
2024
Q1
$1.72M Buy
45,000
+15,000
+50% +$583K 0.57% 27
2023
Q4
$1.35M Buy
30,000
+10,000
+50% +$441K 0.47% 25
2023
Q3
$1.18M Buy
+20,000
New +$1.33M 0.4% 26

Other funds holding VICR

Bruce & Co's VICR Position: Q2 2026 in Review

Bruce & Co reduced its Vicor (VICR) stake by 26% in Q2 2026, selling an estimated $4.64M and leaving 48,000 shares worth $18.2M. The position accounts for 4.93% of the portfolio, ranked #8.

Bruce & Co first reported a position in VICR in Q3 2023 and has held it in 12 quarters since. 514 funds tracked by Wall St. Rank hold VICR as of Q2 2026.

  • Bruce & Co held 48,000 shares of Vicor worth $18.2M as of Q2 2026.
  • Bruce & Co sold 17,000 Vicor shares in Q2 2026, an estimated $4.64M.
  • Vicor made up 4.93% of Bruce & Co's portfolio in Q2 2026, its #8 holding.
  • Bruce & Co first reported a position in Vicor in Q3 2023 and has held it in 12 quarters since.
  • 514 funds tracked by Wall St. Rank held Vicor as of Q2 2026.

Based on Bruce & Co's 13F filing for Q2 2026, filed 14 Aug 2026.